Presentation
Therapeutic Transformation for Patients with Diabetes and CKD
RPA Annual Meeting
Document Type
Presentation
Publication Date
3-20-2021
Keywords
- washington,
- spokane
Disciplines
Abstract
SGLT2 inhibitors represent a major advance in the treatment of patients with chronic kidney disease due to their ability to slow progression of CKD and delay the need for dialysis. They also have been shown to have cardio-protective effects.
Clinical Institute
Kidney & Diabetes
Specialty
Nephrology
Citation Information
Katherine Tuttle. "Therapeutic Transformation for Patients with Diabetes and CKD" RPA Annual Meeting (2021) Available at: http://works.bepress.com/katherine-tuttle/367/